海角破解版

EasySep? Mouse PE Positive Selection Kit II

Immunomagnetic positive selection of PE-conjugated antibody-labeled mouse cells

EasySep? Mouse PE Positive Selection Kit II

Immunomagnetic positive selection of PE-conjugated antibody-labeled mouse cells

Catalog #
(Select a product)
Immunomagnetic positive selection of PE-conjugated antibody-labeled mouse cells
Request Pricing Request Pricing

Product Advantages


  • Fast and easy-to-use

  • No columns required

What's Included

  • EasySep? Mouse PE Positive Selection Kit II (Catalog #17666)
    • EasySep? PE Selection Cocktail, 1 mL
    • Mouse FcR Blocker, 0.1 mL
    • EasySep? Dextran RapidSpheres?, 1 mL
    • RoboSep? Vial For Primary Conjugated Antibody (not required for manual use), 1 vial
  • RoboSep? Mouse PE Positive Selection Kit II (Catalog #17666RF)
    • EasySep? PE Selection Cocktail, 1 mL
    • Mouse FcR Blocker, 0.1 mL
    • EasySep? Dextran RapidSpheres?, 1 mL
    • RoboSep? Vial For Primary Conjugated Antibody (not required for manual use), 1 vial
    • RoboSep? Buffer (Catalog #20104)
    • RoboSep? Filter Tips (Catalog #20125) x 2
  • EasySep? Mouse PE Positive Selection Kit II (Catalog #17696)
    • EasySep? Mouse PE Positive Selection Kit (Catalog #17666) x 5
  • RoboSep? Mouse PE Positive Selection Kit II (Catalog #17696RF)
    • EasySep? Mouse PE Positive Selection Kit (Catalog #17666) x 5
    • RoboSep? Buffer (Catalog #20104) x 5
    • RoboSep? Filter Tips (Catalog #20125) x 10
Products for Your Protocol
To see all required products for your protocol, please consult the Protocols and Documentation.

Overview

Easily isolate highly purified phycoerythrin (PE)-conjugated antibody-labeled mouse cells from mouse splenocytes, bone marrow, or other single-cell suspensions, using immunomagnetic positive selection, with the EasySep? Mouse PE Positive Selection Kit II. Widely used in published research for more than 20 years, EasySep? combines the specificity of monoclonal antibodies with the simplicity of a column-free magnetic system.

In this EasySep? positive selection procedure, desired cells are labeled with antibody complexes recognizing PE and magnetic particles. The kit also contains an antibody to mouse Fc receptor to prevent non-specific binding. Labeled cells are separated using an EasySep? magnet and by simply pouring or pipetting off the unwanted cells. The cells of interest remain in the tube. Following magnetic cell isolation, the desired PE positive cells are ready for downstream applications such as flow cytometry, culture, or cell-based assays.

For highly purified, particle-free cells, we recommend the EasySep? Release Mouse PE Positive Selection Kit (Catalog #17656).

Learn more about how immunomagnetic EasySep? technology works or how to fully automate immunomagnetic cell isolation with RoboSep?. Explore additional products optimized for your workflow, including culture media, supplements, antibodies, and more.
Magnet Compatibility
? EasySep? Magnet (Catalog #18000)
? “The Big Easy” EasySep? Magnet (Catalog #18001)
? EasyEights? EasySep? Magnet (Catalog #18103)
? RoboSep?-S (Catalog #21000)
Subtype
Cell Isolation Kits
Cell Type
B Cells, Dendritic Cells, Granulocytes and Subsets, Hematopoietic Stem and Progenitor Cells, Macrophages, Marrow Stromal Cells, Mesenchymal Stem and Progenitor Cells, Monocytes, Mononuclear Cells, Myeloid Cells, NK Cells, Other, Plasma, T Cells
Species
Mouse
Sample Source
Bone Marrow, Other, Spleen
Selection Method
Positive
Application
Cell Isolation
Brand
EasySep, RoboSep
Area of Interest
Immunology

Data Figures

Starting with mouse splenocytes, the purities of the start and final isolated fractions in the above example are 20.5% and 91.6%, respectively, using a PEconjugated anti-mouse CD4 antibody and EasySep? Mouse PE Positive Selection Kit II.

Protocols and Documentation

Find supporting information and directions for use in the Product Information Sheet or explore additional protocols below.

Document Type
Product Name
Catalog #
Lot #
Language
Document Type
Product Name
Catalog #
17666, 17696
Lot #
All
Language
English
Document Type
Product Name
Catalog #
17696RF, 17666RF
Lot #
All
Language
English
Document Type
Product Name
Catalog #
17666, 17696
Lot #
All
Language
English
Document Type
Product Name
Catalog #
17666, 17696
Lot #
All
Language
English
Document Type
Product Name
Catalog #
17666, 17696
Lot #
All
Language
English
Document Type
Product Name
Catalog #
17696RF, 17666RF
Lot #
All
Language
English
Document Type
Product Name
Catalog #
17696RF, 17666RF
Lot #
All
Language
English
Document Type
Product Name
Catalog #
17696RF, 17666RF
Lot #
All
Language
English
Document Type
Product Name
Catalog #
17696RF, 17666RF
Lot #
All
Language
English

Resources and Publications

Publications (10)

A novel electric field approach for improving cognitive function through ameliorating cell-specific pathology in P301S tauopathy mice J. Zhou et al. Alzheimer's Research & Therapy 2025 Sep

Abstract

Alzheimer’s disease (AD) is a devastating neurodegenerative disorder, with no effective treatment currently available. Recently, non-pharmacological therapy, especially gamma frequency stimulation has shown promising therapeutic effects in Alzheimer’s disease (AD) mouse models. Electric field (EF) is a non-invasive biophysical approach for neuronal protection. However, whether EF is beneficial in AD neuropathology remains unknown. In this study, we exposed the P301S tauopathy mouse model to EF at gamma frequency on the head. We demonstrated that EF treatment significantly improved the cognitive impairments in the P301S mice. This was accompanied by reduced tau pathologies, suppressed microglial activation, neuroinflammation and oxidative stress in the tauopathy mouse brain. Moreover, EF treatment induced cell-specific responses in neural cells, with neurons being more susceptible, followed by microglia and oligodendrocytes. EF also had favorable effects on synaptic protein in neurons, inflammatory response and complement signaling in microglia, and myelination in oligodendrocytes. This study provides strong evidence that EF at gamma frequency may have great potential to be a novel therapeutic intervention for P301S by attenuating neuropathology and offering neuroprotection.Supplementary InformationThe online version contains supplementary material available at 10.1186/s13195-025-01859-8.
Heterogeneity of IL-15-expressing mesenchymal stromal cells controls natural killer cell development and immune cell homeostasis C. Stecher et al. Nature Communications 2025 Jul

Abstract

Bone marrow (BM) mesenchymal stromal cells (MSC) provide microenvironmental niches that support hematopoietic stem cells and regulate hematopoiesis. Whether functional heterogeneity among BM MSCs contributes to the development and survival of distinct immune cell lineages remains incompletely understood. Here, we use an Il15 knockin reporter and multiple conditional deletion mouse models to show distinct differences in IL-15 expression between BM MSC subtypes. Conditional deletion of Il15 in Osx+ stromal cells results in decreased natural killer (NK) cell precursors, memory CD8+ T cells and NKT cells but not mature NK cells. Lepr+ stromal cells support the survival of mature NK cells and memory CD8+ T cells in the BM of older mice, while endothelial cells support mature NK cells and memory CD8+ T cells in the blood but not in the BM. Thus, our data suggest that MSC subtypes differentially regulate the development and survival of IL-15-dependent immune cell lineages in the BM. Microenvironmental niches are instrumental to immune cell development via supporting soluble and contact-dependent differentiation signals. Here authors show that different bone marrow mesenchymal stromal cell subtypes modulate NK cell development via their different Il-15 expression capacities.
Neutrophils promote the activation of monocytes via ROS to boost systemic antitumor immunity after cryo-thermal therapy Frontiers in Immunology 2024 Nov

Abstract

BackgroundThe characteristics of the tumor immunosuppressive microenvironment represent a major challenge that limits the efficacy of immunotherapy. Our previous results suggested that cryo-thermal therapy, a tumor ablation system developed in our laboratory, promotes macrophage M1-type polarization and the complete maturation of DCs to remodel the immunosuppressive environment. However, the cells that respond promptly to CTT have not yet been identified. CTT can cause extensive cell death and the release of danger-associated molecular patterns and antigens. Neutrophils are the first white blood cells recruited to sites of damage and acute inflammation. Therefore, we hypothesized that neutrophils are the initial cells that respond to CTT and are involved in the subsequent establishment of antitumor immunity.MethodsIn this study, we examined the kinetics of neutrophil recruitment after CTT via flow cytometry and immunofluorescence staining and explored the effect of neutrophils on the establishment of systemic antitumor immunity by in vivo neutrophil depletion and in vitro co-culture assays.ResultsWe found that CTT led to a rapid and strong proinflammatory neutrophil response, which was essential for the long-term survival of mice. CTT-induced neutrophils promoted the activation of monocytes via reactive oxygen species and further upregulated the expression of IFN-γ and cytotoxic molecules in T and NK cells. Adoptive neutrophil transfer further enhanced the antitumor efficacy of CTT in tumor models of spontaneous and experimental metastasis.ConclusionThese results reveal the important role of neutrophil?monocyte interactions in the development of anti-tumor immunity and highlight that CTT could be used as an immunotherapy for targeting neutrophils and monocytes to enhance antitumor immunity.